Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 17 04:00PM ET
Dollar change
Percentage change
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y11.01% Shs Outstand Perf Week3.57%
SponsorFranklin Templeton ETF Type Tagsequity Return% 3Y-11.87% Total Holdings63 Perf Month5.34%
Fund Family Bond Type Tagshealthcare Return% 5Y- AUM10.20M Perf Quarter9.73%
Index- Average Maturity Tagsgenomics Return% 10Y NAV% Perf Half Y12.35%
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year8.71%
Active/Passive Quant Type Tags- Flows% 1M0.00% 52W Range25.26 - 33.98 Perf YTD9.51%
Dividend TTM- ESG Type Tags- Flows% 3M0.00% 52W High-1.79% Beta1.07
Dividend Ex-DateDec 30, 2021 Dividend Type Sector/Theme Flows% YTD-12.83% 52W Low32.10% ATR (14)0.33
Expense0.50% Structure Type Region Flows% 1Y RSI (14)65.33 Volatility0.88% 0.46%
Option/ShortYes / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume2.35 Prev Close33.98
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume1.37K Price33.37
SMA204.11% SMA505.12% SMA20010.42% Trades Volume3,211 Change-1.79%
Jul-16-21 11:19AM
Jan-14-21 09:15AM
Oct-05-20 08:00AM
Franklin Genomic Advancements ETF seeks capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.